Skip to main content
×
×
Home

Off-label prescribing by psychiatrists

  • Francesca L. Lowe-Ponsford (a1) and David S. Baldwin (a2)
Extract

A questionnaire was sent to 200 psychiatrists asking them about their off-label prescribing in the preceding month. One hundred and sixteen replies (58%) were obtained. Seventy-six (65%) respondents had prescribed medication off-label within the past month. Only 5 (4%) had ever received a complaint from patients related to their off-label prescribing. If this region is typical, off-label prescribing is common amongst psychiatrists. No formal guidelines exist except for the use of high dose neuroleptics. A suggested guideline is given in this article.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Off-label prescribing by psychiatrists
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Off-label prescribing by psychiatrists
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Off-label prescribing by psychiatrists
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Association of the British Pharmaceutical Industry (1999) ABPI Compendium of Data Sheets and Summaries of Product Characteristics 1999–2000. London: Datapharm Publications Limited.
British Association for Psychopharmacology (1997) BAP consensus statement. Child and learning disability psychopharmacology. Journal of Psychopharmacology, 11, 291294.
British Medical Association & Royal Pharmaceutical Society of Great Britain (1999) British National Formulary. London: Wallingford: BMJ Books. Pharmaceutical Press.
Conroy, S., Choonare, I., Impicciatore, P., et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. British Medical Journal, 320, 7982.
Healy, D. & Nutt, D. (1998) Prescriptions, licences and evidence. Psychiatric Bulletin, 22, 680684.
Lowe-Ponsford, F. L. (1999) Anticonvulsants in the treatment of bipolar disorder. In Practical Issues in Mood and Anxiety Disorders. No. 8. The Netherlands: SmithKline Beecham.
Milton, J., Lawton, J., Smith, M., et al (1998) Hidden high-dose antipsychotic prescribing: effects of p.r.n. doses. Psychiatric Bulletin, 22, 675677.
Thompson, C. (for the Royal College of Psychiatrists' Panel) (1994) The use of high-dose antipsychotic medication (Consensus statement). British Journal of Psychiatry, 164, 448458.
Vitello, B. & Jensen, P. S. (1997) Medication development and testing in children and adolescents. Archives of General Psychiatry, 54, 871876.
Bolam v. Friern Hospital Management Committee [1957] WLR, 582.
Bolitho v. City and Hackney Health Authority [1997] 3WLR, 1151.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 3
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 36 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 22nd July 2018. This data will be updated every 24 hours.

Off-label prescribing by psychiatrists

  • Francesca L. Lowe-Ponsford (a1) and David S. Baldwin (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *